Deutsche Bank’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,169
Closed -$144K 3995
2022
Q2
$144K Buy
1,169
+803
+219% +$94.2K ﹤0.01% 3343
2022
Q1
$43K Sell
366
-46
-11% -$7.61K ﹤0.01% 3880
2021
Q4
$107K Sell
412
-372
-47% -$113K ﹤0.01% 3676
2021
Q3
$214K Buy
784
+384
+96% +$111K ﹤0.01% 3532
2021
Q2
$171K Buy
+400
New +$152K ﹤0.01% 3870
2020
Q1
Sell
-20
Closed -$2K 4436
2019
Q4
$2K Buy
+20
New +$2.21K ﹤0.01% 4820

Other funds holding DRIO

Deutsche Bank's DRIO Position: Q3 2022 in Review

Deutsche Bank sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 1,169 shares — an estimated $144K sold.

Deutsche Bank first reported a position in DRIO in Q4 2019 and held it in 6 quarters. The position peaked at $214K in Q3 2021. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

  • Deutsche Bank reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,169 DarioHealth shares in Q3 2022, an estimated $144K.
  • Deutsche Bank first reported a position in DarioHealth in Q4 2019 and held it in 6 quarters.
  • Deutsche Bank's DarioHealth position peaked at $214K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on Deutsche Bank's 13F filing for Q3 2022, filed 14 Nov 2022.